BioMEMS Market - Industry Analysis, Market Size, Share, Trends, Growth And Forecast 2022-2027

Report Code: AIR 0357 Report Format: PDF + Excel

BioMEMS Market Overview

The Global BioMEMS Market size is forecast to reach $15.5 billion by 2027, growing at a CAGR of 11.68% from 2022 to 2027. Growing technological advancement in biomedical research, medical micro-devices, biomedicine and others have been eventually driving the need for Biological Micro-Electro-Mechanical Systems (BioMEMS) market. Rising demand for BioMEMS devices applying traditional micro fabrication and microfluidics technology utilizing micro-sensors, actuators, transducers, and electronic components are some of the prime factors driving the global BioMEMS market. Furthermore, with growing adoption of micro total analysis system as a part of automating all biochemical analysis while ensuring optimization of diagnostic and therapeutic applications, BioMEMS devices has gained a huge traction. Growing incorporation of biomolecules as an integral part of the device is augmenting the market. Increasing proliferation of advanced genomics, proteomics and other biotechnology techniques is analyzed to create significant growth opportunities for BioMEMS market in the future years.

BioMEMS Market Report Coverage

The report: “BioMEMS Industry Outlook – Forecast (2022-2027)”, by IndustryARC covers an in-depth analysis of the following segments of the BioMEMS industry.

By Type – MEMS Sensors, Micro fluids, Others.
By Material -Silicon and Glass, Plastics and Polymers, Paper, Biological Material.
By Product – Injectables, Implantables (stents, gyroscopes, accelerometers, biochips, biosensors and drug delivery devices), Others.
By Application – Therapeutic, Tissue Engineering, Diagnostic, Others.
By End User -Home diagnostics, healthcare, pharmaceutical, research centers, agriculture, food, others.
By Geography - North America (U.S, Canada, Mexico), Europe(Germany, UK, France, Italy, Spain, Russia and Others), APAC(China, Japan India, South Korea, Australia and Others), South America(Brazil, Argentina and others), and RoW (Middle east and Africa). 

Key Takeaways

  • BioMEMS sensor is analyzed to witness highest growth in the BioMEMS Market during 2022-2027 owing to growing integration of MEMS sensors with medical devices.
  • North America BioMEMS Market held the largest share in 2021, attributing to factors like early adoption of IoT in medical research and high investments towards advanced technology in biomedical research, medical micro-devices, biomedicine and others.
  • Increasing penetration of wearable medical devices among the geriatric population to improve remote diagnostics and monitoring along with growing integration of nanotechnology with Bio-MEMS supporting cellular interaction at molecular level are analyzed to significantly drive the global BioMEMS Market during the forecast period 2022-2027.

Global BioMEMS Market Value Share, by Geography, 2021, (%)

Global BioMEMS Market Value Share, by Geography

For more details on this report - Request for Sample

BioMEMS Segment Analysis- By Type

By type, global BioMEMS Market has been segmented into MEMS Sensors, Microfuids, Others. Sensors is analyzed to grow with the highest CAGR of 42.8% during the forecast period 2022-2027. Integration of bioMEMS sensors with medical devices with an aim to optimize next-generation sequencing (NGS), drug delivery systems, Point-of-Care diagnostics and precision micro tools capabilities are one of the prime factors boosting the market growth over time. BioMEMS sensors aids in developing high throughput screening methods in order to detect biological components with maximized precision. According to a report of HIT Infrastructure published on June 2021, 59% of healthcare organizations are currently deploying the internet of things (IoTs) to advance remote monitoring, while 35% of them have already planned to deploy IoTs in near future. In February 2019, Sensera, a global leader in providing IoT solution and sensor based products announced about expanding its micro-fabrication capabilities as a part of delivering commercially viable lab-on-a-chip and organ-on a chip diagnostics solutions to increase the efficacy of detection in biological components for diagnostics purposes. Such factors are further set to propel the market growth of global BioMEMS Market in the long run. 

BioMEMS Segment Analysis- By End Users

By end users, BioMEMS Market has been segmented into Home diagnostics, healthcare, pharmaceutical, research centers, agriculture, food and others. Pharmaceutical sector dominated the global BioMEMS Market with a share of 20.1% in 2021, and is analyzed to have a significant growth during 2022-2027. Rising shifts towards microfabricated platforms incorporated with BioMEMS and nanofabricated devices along with the growth in biomedicine is likely to continue in coming years, which in turn will increase the demand for BioMEMS devices. Growing adoption of BioMEMS devices in pharmaceutical sector to optimize the efficacy of therapeutics by integrating technologies like targeted drug delivery, timed drug release, and triggered drug release is resulting in speedy expansion of the market. In November 2021, Debiopharm, a Swiss biopharmaceutical company, announced about investing $4 million in Mekonos, a biotech company, involved in building the future of cell therapies on a chip. This investment was done with an aim to bolster the expansion of MEMS, Microfluidics, Biology, and Business Development functions of Mekonos to enhance the development of novel drug delivery systems. Such factors will fuel the growth of BioMEMS market in coming years.

BioMEMS Segment Analysis- By Geography

By Geography, BioMEMS Market has been segmented into North America, Europe, APAC, South America and Others. North America dominated the global BioMEMS Market with a share of 36% in 2021, owing to huge investments in healthcare sector and medical research. Rising investment towards innovative therapeutics or growth in biopharma industry is one of the key factors driving its market growth within the region. Factors such as rising disease awareness, well established health infrastructure, high investment towards domestic manufacturing of medical devices are the key factors fostering BioMEMS market in this region.

In 2020, the U.S. federal government announced about an investment of $11 billion in late-stage vaccine development and expansion of manufacturing capacity through Operation Warp Speed and the Biomedical Advanced Research and Development. Such governmental initiatives are set to create significant growth opportunities for the market during 2022-2027.

BioMEMS Market Drivers

Increasing penetration of wearable medical devices among the geriatric population to improve remote diagnostics and monitoring are impacting the market growth

Increasing penetration of mobile devices and wearable as a part of accelerating health condition monitoring including diabetes, blood pressure, blood gas monitoring and so on among the geriatric population acts as major factor driving the market growth towards global BioMEMS market.  Growth in adoption of home care devices among consumers enabling remote diagnostics and monitoring is augmenting the market. Increasing integration of bioMEMS into such wearable and modules for mobile devices can be considered vital in boosting the market. The recent trend of shifting towards miniaturized systems using MEMS devices or MEMS technology is holding significant potential for growth in healthcare sector. The burgeoning demand for mobile care applications and patient monitoring equipment aids in the early diagnosis of disease indications, and such factors will propel the global BioMEMS market in Healthcare sector In July 2020, The Indiana Biosciences Research Institute (IBRI) announced about developing a handheld device, called the BioMEMS Analyzer which would help in detecting biomolecules within a sample. This mobile device was developed to bolster rapid detection of resistant infections, and is set to fuel the market growth in the long run.

Growing integration of nanotechnology with Bio-MEMS supporting cellular interaction at molecular level drives its market forward

Growing integration of nanotechnology with Bio-MEMS supporting cellular interaction at molecular level act as a major driver boosting its market growth. In, nanotechnology integrated Bio-MEMS devices exhibits beneficiary capabilities such as low power consumption and lower production costs owing to its small size, which in turn are contributing towards the growth of the market Furthermore, with the substantial growth of medical field, biomedicine and bio-technology are evolving and adopting technological advancements. New developments in devices like accelerometers, drug delivery systems and gyroscopes or adoption of emerging technologies like DNA or microprotein arrays, enzyme-linked immuno-sorbent assay, and fluorescence resonance energy transfer-based analysis in medical field are the few factors boosting the market growth over time.

BioMEMS Market Challenges

High cost associated with extensive research & development and expensive upfront setup hinders its market growth

BioMEMS incurs high costs associated with its extensive R&D, installation, integration, deployment and additional maintenance services owing to its robust infrastructure combined with stringent security policies. Many medical equipment manufacturing and pharmaceutical companies are limiting its adoption due to high financial requirement. Traditional healthcare sector never had to invest in advanced technology thus many of them are still reluctant to adopt this technology due to limited budget allocation. Such factors have been creating an adverse impact on its market growth.

BioMEMS Industry Outlook

Product innovations, acquisitions, Partnerships and R&D activities are key strategies adopted by players in the market. BioMEMS top 10 companies include:

  1. Oxford Instruments
  2. Philips Engineering Solution
  3. Taylor Hobson
  4. Teledyne DALSA
  5. Micron Technology
  6. OMRON
  7. MEC Company LTD
  8. Amphenol
  9. TE Connectivity
  10. Boehringer Ingelheim

Recent Developments

  • In October 2021, Boehringer Ingelheim announced about the launch of biopharmaceutical production facility Large Scale Cell Culture (LSCC) in Vienna, Austria to accelerate digitalization and automation through smart technologies and artificial intelligence applications. This multi-product plant and flexible line structures was established to enable production of a large variety of molecule formats.
  • In July 2021, OMRON Healthcare, announced about the launch of OMRON Complete, its first single-lead electrocardiogram (ECG) and blood pressure monitor for home use. This product launch was done to expand the product portfolio of IoT enabled medical devices.

Relevant Report Titles:

Microfluidic Sensor Market – Forecast (2022 - 2027)
Report Code: AIR 0358

Micro-Electro Mechanical Systems (MEMS) Market-Forecast (2022 - 2027)
Report Code: ESR 0002

For more Automation and Instrumentation related reports, please click here

1. BioMEMS Market Overview
    1.1 Definitions and Scope
2. BioMEMS Market - Executive Summary
    2.1 Market Revenue, Market Size and Key Trends by Company
    2.2 Key trends by End user
    2.3 Key trends segmented by Geography
3. BioMEMS Market Landscape
    3.1 Comparative Analysis
        3.1.1 Product/Service Benchmarking-Top 5 Companies
        3.1.2 Top 5 Financial Analysis
        3.1.3 Market Value Split by Top 5 Companies
        3.1.4 Patent Analysis
        3.1.5 Pricing Analysis
4. BioMEMS Market – By Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital Funding
5. BioMEMS Market – By Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Framework
    5.2 Customer Analysis
    5.3 Case Studies
    5.4 Ease of Doing Business Index
6. BioMEMS Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Network of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Network of substitutes
7. BioMEMS Market – By Strategic Analysis (Market Size -$Million/Billion)
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Product Life Cycle/Market Life Cycle Analysis
    7.4 Vendors & Partners
8. BioMEMS Market – By Type
    8.1 MEMS sensors
    8.2 Micro fluid
    8.3 Others
9. BioMEMS Market – By Material
    9.1 Silicon and glass
    9.2 Plastic and polymers
    9.3 Paper
    9.4 Biological material
10. BioMEMS Market – By Product
    10.1 Injectables
    10.2 Implantables
        10.2.1 Stent
        10.2.2 Gyroscope
        10.2.3 Accelerometers
        10.2.4 Biochips
        10.2.5 Biosensors & drug delivery devices
        10.2.6 Others
11. BioMEMS Market - By Application
    11.1 Therapeutic
    11.2 Tissue Engineering
    11.3 Ddiagnostics
    11.4 Others
12. BioMEMS Market - By End Users
    12.1 Home Diagnostics
    12.2 Healthcare
    12.3 Pharmaceutical
    12.4 Research center
    12.5 Agriculture
    12.6 Food
    12.7 Others
13. BioMEMS Market – By Region
    13.1 North America
        13.1.1 U.S
        13.1.2 Canada
        13.1.3 Mexico
    13.2 Europe
        13.2.1 Germany
        13.2.2 France
        13.2.3 UK
        13.2.4 Italy
        13.2.5 Spain
        13.2.6 Others
    13.3 APAC
        13.3.1 China
        13.3.2 Japan
        13.3.3 South Korea
        13.3.4 India
        13.3.5 Australia
        13.3.6 Others
    13.4 South America
        13.4.1 Brazil
        13.4.2 Argentina
        13.4.3 Others
    13.5 RoW
        13.5.1 Middle East
        13.5.2 Africa
14. BioMEMS Market - Industry Landscape Analysis (Premium)
    14.1 Market Share by Region
    14.2 Market Share by End Users
    14.3 Market Share by Deployment Model
15. BioMEMS Market - Key Companies by Country (Premium)
16. BioMEMS Market Entropy
    16.1 New Product Launches
    16.2 M&As, Collaborations, JVs and Partnerships
17. BioMEMS Market - Company Analysis
    17.1 Oxford Instruments
    17.2 Philips Engineering Solution
    17.3 Taylor Hobson
    17.4 Teledyne DALSA
    17.5 Micron Technology
    17.6 OMRON
    17.7 MEC Company LTD
    17.8 Amphenol
    17.9 TE Connectivity
    17.10 Boehringer Ingelheim